Before we move forward with the global market performance, let's have a glance on the important update based out of the Australian vaccine production. Australian vaccine manufacturing has fallen behind. After the QLD university’s biotech attempt to create a vaccine failed to pass the medical regulator’s clinical trials.
ASX 200 witnessing a sluggish trade during early trade hours. However, the index later picked up momentum, crossing the 7100 mark for the first time since last year’s March/April market dip. Healthcare, financial, energy and miners majorly are pulling up the ASX chords, overshadowing the tech sector rout. Health
stocks jumped most in 6 weeks on U.S. dollar strength, while energy stocks are soaring amid rising oil prices. The first one in the list os the stock of the aerial imagery technology and location data company Nearmap Ltd surged 15.5% to the intra-day high of AU$2.38. The stock has gained following a positive announcement by the firm after market close on Tuesday.